Management of myelofibrosis during pregnancy: A case report
Introduction. Primary myelofibrosis (PMF) is a clonal myeloproliferative neoplasm that occurs most commonly in the decade six of life and it is very rare in the young persons. Case report. We reported a 28-year-old female patient with primary myelofibrosis who had a normal pregnancy and del...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Military Health Department, Ministry of Defance, Serbia
2015-01-01
|
Series: | Vojnosanitetski Pregled |
Subjects: | |
Online Access: | http://www.doiserbia.nb.rs/img/doi/0042-8450/2015/0042-84501504383Z.pdf |
id |
doaj-367e2ea0730f43dcba99bb7585d61a7c |
---|---|
record_format |
Article |
spelling |
doaj-367e2ea0730f43dcba99bb7585d61a7c2020-11-24T22:53:27ZengMilitary Health Department, Ministry of Defance, SerbiaVojnosanitetski Pregled0042-84502015-01-0172438338510.2298/VSP1504383Z0042-84501504383ZManagement of myelofibrosis during pregnancy: A case reportŽivković Radmila0Marković Olivera1Marisavljević Dragomir2Terzić Tatjana3Tukić Ljiljana4Clinical Hospital Center ”Bežanijska kosa“, Department of Hematology, BelgradeClinical Hospital Center ”Bežanijska kosa“, Department of Hematology, Belgrade + Faculty of Medicine, BelgradeClinical Hospital Center ”Bežanijska kosa“, Department of Hematology, Belgrade + Faculty of Medicine, BelgradeFaculty of Medicine, Institute of Pathology, BelgradeMilitary Medical Academy, Clinic of Hematology, Belgrade + University of Defence, Faculty of Medicine of the Military Medical Academy, BelgradeIntroduction. Primary myelofibrosis (PMF) is a clonal myeloproliferative neoplasm that occurs most commonly in the decade six of life and it is very rare in the young persons. Case report. We reported a 28-year-old female patient with primary myelofibrosis who had a normal pregnancy and delivery in the week 40 of pregnancy without any complications. Two years before the diagnosis of PMF she had normal pregnancy. The patient was treated with interferon-alpha and low dose aspirin during the whole pregnancy and with low-molecular-weight heparin a week before delivery and 6 weeks after. The patient had no complications during pregnancy. She delivered in term with healthy, normal baby weight. Conclusion. Decision about treatment strategy of pregnancy associated hematologic malignancies should be made for each patient individually.http://www.doiserbia.nb.rs/img/doi/0042-8450/2015/0042-84501504383Z.pdfmyeloproliferative disordersprimary myelofibrosispregnancyinterferon-alphatreatment outcome |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Živković Radmila Marković Olivera Marisavljević Dragomir Terzić Tatjana Tukić Ljiljana |
spellingShingle |
Živković Radmila Marković Olivera Marisavljević Dragomir Terzić Tatjana Tukić Ljiljana Management of myelofibrosis during pregnancy: A case report Vojnosanitetski Pregled myeloproliferative disorders primary myelofibrosis pregnancy interferon-alpha treatment outcome |
author_facet |
Živković Radmila Marković Olivera Marisavljević Dragomir Terzić Tatjana Tukić Ljiljana |
author_sort |
Živković Radmila |
title |
Management of myelofibrosis during pregnancy: A case report |
title_short |
Management of myelofibrosis during pregnancy: A case report |
title_full |
Management of myelofibrosis during pregnancy: A case report |
title_fullStr |
Management of myelofibrosis during pregnancy: A case report |
title_full_unstemmed |
Management of myelofibrosis during pregnancy: A case report |
title_sort |
management of myelofibrosis during pregnancy: a case report |
publisher |
Military Health Department, Ministry of Defance, Serbia |
series |
Vojnosanitetski Pregled |
issn |
0042-8450 |
publishDate |
2015-01-01 |
description |
Introduction. Primary myelofibrosis (PMF) is a clonal myeloproliferative
neoplasm that occurs most commonly in the decade six of life and it is very
rare in the young persons. Case report. We reported a 28-year-old female
patient with primary myelofibrosis who had a normal pregnancy and delivery in
the week 40 of pregnancy without any complications. Two years before the
diagnosis of PMF she had normal pregnancy. The patient was treated with
interferon-alpha and low dose aspirin during the whole pregnancy and with
low-molecular-weight heparin a week before delivery and 6 weeks after. The
patient had no complications during pregnancy. She delivered in term with
healthy, normal baby weight. Conclusion. Decision about treatment strategy of
pregnancy associated hematologic malignancies should be made for each patient
individually. |
topic |
myeloproliferative disorders primary myelofibrosis pregnancy interferon-alpha treatment outcome |
url |
http://www.doiserbia.nb.rs/img/doi/0042-8450/2015/0042-84501504383Z.pdf |
work_keys_str_mv |
AT zivkovicradmila managementofmyelofibrosisduringpregnancyacasereport AT markovicolivera managementofmyelofibrosisduringpregnancyacasereport AT marisavljevicdragomir managementofmyelofibrosisduringpregnancyacasereport AT terzictatjana managementofmyelofibrosisduringpregnancyacasereport AT tukicljiljana managementofmyelofibrosisduringpregnancyacasereport |
_version_ |
1725663367867138048 |